An international role for nomenclature through INNs

WHO Drug Information

Volumn 18, Issue 2, 2004, Pages 123-126

  Sashkova, Galina ^a   Setzenov, I M ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; GENERIC DRUG;

DRUG INDUSTRY; DRUG MARKETING; DRUG NOMENCLATURE; INTERNATIONAL COOPERATION; INTERNATIONAL NONPROPRIETARY NAME; PATENT; PRESCRIPTION; REVIEW; WORLD HEALTH ORGANIZATION;

EID: 4344625960     PISSN: 10109609     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (7)

1. World Health Organization. Guidelines on the use of international nonproprietary nams (INNs) for pharmaceutical substances. WHO/PHARMS/NOM 1570 (1997).
2. World Health Organization. International nonproprietary names (INN) for pharmaceutical substances. Cumulative list No. 10 (CD-ROM) (2002).
3. Art. 1 point 21 of the Directive 2001/83/EC of 6 November 2001 on the Community Code related to medicinal products for human use.
4. EMEA. Committee for Human Medicinal Products (CHMP). Guideline on the acceptability of invented names for human medicinal products processed through the centralized procedure. CPMP/328/98 Rev. 4. (2004).
5. World Health Organization. The graphic representation of chemical formulae in the publication of international nonproprietary names (INN) for pharmaceutical substances. WHO/PHARM/9.579 (1995)
6. World Health Organization. The use of common stems in the selection of international nonproparietary names for pharmaceutical substances. WHO/EDM/QSM/2003.2 (2002).
7. World Health Organization. International nonproprietary names for pharmaceutical substances. Names of radicals and groups, comprehensive list. WHO/EDM/QSM/2003.1 (2002).